Stereotactic Ablative Radiotherapy for Oligo-Progressive Cancers: Results of the Randomized Phase II STOP Trial

Autor: Schellenberg, D., Gabos, Z., Duimering, A., Debenham, B.J., Fairchild, A., Huang, F., Rowe, L., Severin, D.M., Giuliani, M., Bezjak, A., Lok, B.H., Raman, S., Chung, P., Zhao, Y., Ho, C., Lock, M.I., Louie, A., Lefresne, S., Carolan, H., Liu, M.C., Yau, V., Ye, A.Y., Olson, R.A., Mou, B., Mohamed, I.G., Petrik, D.W., Dosani, M., Pai, H.H., Valev, B., Gaede, S., Warner, A., Palma, D.A.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 October 2023 117(2) Supplement:S58-S58
Databáze: ScienceDirect